Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes.

Stähli, Barbara E; Wischnewsky, Manfred B; Jakob, Philipp; Klingenberg, Roland; Obeid, Slayman; Heg, Dik; Räber, Lorenz; Windecker, Stephan; Roffi, Marco; Mach, François; Gencer, Baris; Nanchen, David; Jüni, Peter; Landmesser, Ulf; Matter, Christian M; Lüscher, Thomas F; Maier, Willibald (2018). Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes. International journal of cardiology, 270, pp. 7-13. Elsevier 10.1016/j.ijcard.2018.05.134

Text Stähli IntJCardiol 2018.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (9MB)

BACKGROUND

This study sought to investigate the predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes (ACS). The ACEF score (age/left ventricular ejection fraction +1 [if creatinine > 176 μmol/L]) has been established in patients evaluated for coronary artery bypass surgery. Data on its predictive value in all-comer ACS patients undergoing percutaneous coronary intervention are scarce.

METHODS

A total of 1901 patients prospectively enrolled in the Swiss ACS Cohort were included in the analysis. Optimal ACEF score cut-off values were calculated by decision tree analysis, and patients divided into low-risk (≤1.45), intermediate-risk (>1.45 and ≤2.0), and high-risk groups (>2.0). The primary endpoint was all-cause mortality. Major adverse cardiac and cerebrovascular events (MACCE) included all-cause death, non-fatal myocardial infarction, clinically indicated repeat coronary revascularization, definite stent thrombosis, and transient ischemic attack/stroke.

RESULTS

One-year rates of all-cause death increased across ACEF score groups (1.6% versus 5.6% versus 23.0%, p < 0.001). In multivariate analysis, the ACEF score was related with an increased risk of all-cause mortality (adjusted HR 3.53, 95% CI 2.90-4.31, p < 0.001), MACCE (adjusted HR 2.23, 95% CI 1.88-2.65, p < 0.001), and transient ischemic attack/stroke (adjusted HR 2.58, 95% CI 1.71-3.89, p < 0.001) at 1 year. Rates of Thrombolysis in Myocardial Infarction (TIMI) major and Global use of Strategies to Open Occluded Coronary Arteries (GUSTO) severe bleeding paralleled the increased ischemic risk across the groups (p < 0.001).

CONCLUSIONS

The ACEF score is a simple and useful risk stratification tool in patients with ACS referred for coronary revascularization.

Interest & Impact

Downloads

3 since deposited on 21 Jun 2018
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item